Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s share price traded up 0.5% during trading on Friday . The company traded as high as $19.50 and last traded at $19.50. 300 shares changed hands during trading, a decline of 34% from the average session volume of 453 shares. The stock had previously closed at $19.40.
Hikma Pharmaceuticals Price Performance
The stock has a fifty day moving average of $17.80 and a 200-day moving average of $19.87. The company has a quick ratio of 1.06, a current ratio of 1.82 and a debt-to-equity ratio of 0.57.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.
Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Japan’s Stealth Bull Market: How U.S. Investors Can Get Exposure
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
